We are live on
!
Find out more
NC
Nicholas Company Portfolio holdings
AUM
$5.1B
1-Year Est. Return
8.43%
This Fund
S&P 500
This Quarter
Est. Return
+8.79%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$4.58B
AUM Growth
+$298M
(+7%)
Cap. Flow
-$45M
Cap. Flow
% of AUM
-0.98%
Top 10 Holdings %
Top 10 Hldgs %
20.03%
Holding
233
New
17
Increased
71
Reduced
108
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intercontinental Exchange
ICE
|
+$30M |
| 2 |
Comcast
CMCSA
|
+$21.7M |
| 3 |
Quest Diagnostics
DGX
|
+$18M |
| 4 |
Smith & Nephew
SNN
|
+$15.7M |
| 5 |
Revvity
RVTY
|
+$12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$35.9M |
| 2 |
Thermo Fisher Scientific
TMO
|
+$13.6M |
| 3 |
Keurig Dr Pepper
KDP
|
+$13.6M |
| 4 |
Mastercard
MA
|
+$12.6M |
| 5 |
CAVM
Cavium, Inc.
CAVM
|
+$12.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.48% |
| 2 | Healthcare | 18.1% |
| 3 | Consumer Discretionary | 14.59% |
| 4 | Financials | 14.49% |
| 5 | Industrials | 13.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PARA
226
DELISTED
Paramount Global Class B
PARA
| – | – |
-637,950
| Closed | -$35.9M |
|
227
Veeva Systems
VEEV
$33.6B
| – | – |
-48,190
| Closed | -$3.7M |
|
228
Dentsply Sirona
XRAY
$2.78B
| – | – |
-183,280
| Closed | -$8.02M |
|
|
AGN
229
DELISTED
Allergan plc
AGN
| – | – |
-3,199
| Closed | -$533K |
|
|
WPZ
230
DELISTED
Williams Partners L.P.
WPZ
| – | – |
-97,611
| Closed | -$3.96M |
|
|
CAVM
231
DELISTED
Cavium, Inc.
CAVM
| – | – |
-141,265
| Closed | -$12.2M |
|
Similar funds
VT
CS
EIC
AC
CIA
TAM
CTC
BG
Nicholas Company's Q3 2018 Portfolio in Review
As of Q3 2018, Nicholas Company held 233 positions worth $4.58B, up 7% from $4.28B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Nicholas Company's Q3 2018 filing shows 17 new, 71 increased, 108 reduced and 8 closed positions. Its largest new stake was Intercontinental Exchange: 399,515 shares worth $29.9M. The largest sale was Paramount Global Class B, an estimated $35.9M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Nicholas Company's largest Q3 2018 buy was Intercontinental Exchange: 399,515 shares worth $29.9M.
- Nicholas Company added most to Quest Diagnostics in Q3 2018, an estimated $18M increase.
- Nicholas Company's biggest Q3 2018 reduction was Thermo Fisher Scientific, cutting an estimated $13.6M.
- Nicholas Company fully exited Paramount Global Class B in Q3 2018, selling an estimated $35.9M.
- Nicholas Company's ten largest holdings make up 20% of its $4.58B portfolio in Q3 2018.
- Nicholas Company opened 17 new positions and closed 8 in Q3 2018.
- Nicholas Company's portfolio value rose 7% quarter-over-quarter to $4.58B.
Based on Nicholas Company's 13F filing for Q3 2018, filed 14 Nov 2018.